首页> 外国专利> Methods for assessing pregnancy outcome

Methods for assessing pregnancy outcome

机译:评估怀孕结果的方法

摘要

The invention relates to a method of assessing pregnancy outcome. The inventors investigated endometrial miRNAs associated with pregnancy outcome by studying miRNAs associated with endometrial receptivity, implantation failure and embryo miscarriage. They performed a miRNomic study to find miRNAs that are differentially expressed according to the endometrial receptivity status, compared the endometrial miRNome between receptive patients with negative beta-hCG and receptive patients with positive beta-hCG, and compared the endometrial miRNome between receptive patients with a miscarriage between 8-12 weeks of amenorrhoea and receptive patients with a live birth. They demonstrated miRNA differential expression in endometrial samples according to the pregnancy outcome. Thus, the invention relates to a method of assessing pregnancy outcome of a patient, comprising a step of measuring in a biological sample obtained from the patient the expression level of at least one miRNA selected from the group consisting of miR-455-3 p, miR-4423-3p, miR-4445-3p, miR-3128, miR-3201, let-7b-5p, let-7c-5p, miR-4534, miR-214-3p, miR-15b-5p, miR-424-3p, miR-181a-5p, miR-574-3p, miR-92a-3 p, miR-320c, let-7d-5p, miR-125a-5p, miR-320a, miR-320b and let-7f-5p.
机译:本发明涉及评估妊娠结果的方法。本发明人通过研究与子宫内膜接受,植入失败和胚胎流产相关的miRNA来研究与妊娠结局相关的子宫内膜miRNA。它们进行了术语,用于发现根据子宫内膜接受状态差异表达的miRNA,对比β-HCG的接受患者的子宫内膜mirNome与阳性β-HCG的接受患者进行了比较,并比较了接受患者的子宫内膜mirNome闭塞在8-12周的闭经和活生生患者之间。它们根据怀孕结果证明了子宫内膜样品中的miRNA差异表达。因此,本发明涉及评估患者妊娠结束的方法,包括在从患者获得的生物样品中测量的步骤,所述生物样品中的至少一种选自miR-455-3 p的miRNA的表达水平, miR-4423-3p,miR-4445-3p,miR-3128,miR-3201,let-7b-5p,let-7c-5p,miR-4534,miR-214-3p,miR-15b-5p,mir- 424-3P,MIR-181A-5P,MIR-574-3P,MIR-92A-3 P,MIR-320C,Let-7D-5P,MIR-125A-5P,MIR-320A,MIR-320B和Let-7F -5P。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号